The US Senate on 21 April approved a $484bn spending package providing tens of billions of dollars to compensate Medicare suppliers that have already supplied diagnoses, testing supplies and personal protection equipment (PPE) to detect the coronavirus, and $25bn more to expand COVID-19 testing.
House members, almost all of whom are self-quarantining or working in their home districts since the end of March, have been summoned back to Washington, DC, by House Speaker Nancy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?